Expression of RUNX3 in skin cancers

Clinical and Experimental Dermatology

Volumn 36, Issue 7, 2011, Pages 769-774

  Lee, J H ^a   Pyon, J K ^b   Kim, D W ^c   Lee, S H ^c   Nam, H S ^c   Kang, S G ^c   Kim, C H ^c   Lee, Y J ^c   Chun, J S ^c   Cho, M K ^c  

^a Hanyang University Guri Hospital   (South Korea)

^b Sungkyunkwan University   (South Korea)

^c Soonchunhyang University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

SMALL INTERFERING RNA;

ARTICLE; CANCER INHIBITION; CELL FRACTIONATION; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MELANOMA; ONCOGENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RUNX3 ONCOGENE; SKIN CANCER; SQUAMOUS CELL CARCINOMA; WESTERN BLOTTING;

AGED; AGED, 80 AND OVER; BLOTTING, WESTERN; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; CELL LINE; CELL NUCLEUS; CELL PROLIFERATION; CORE BINDING FACTOR ALPHA 3 SUBUNIT; FEMALE; GENE EXPRESSION REGULATION; GENE SILENCING; HUMANS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM PROTEINS; RNA, SMALL INTERFERING; SKIN; SKIN NEOPLASMS;

EID: 80052970314     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2011.04069.x     Document Type: Article

References (20)

1. Jemal A, Thomas A, Murray T, et al. Cancer statistics, 2002. CA Cancer J Clin 2002; 52: 23-47. (Pubitemid 34110469)
2. Lund AH, Lohuizen M,. RUNX. A trilogy of cancer genes. Cancer Cell 2002; 1: 213-15.
3. Ito Y,. Oncogenic potential of the RUNX gene family: 'overview'. Oncogene 2004; 23: 4198-208. (Pubitemid 38765135)
4. Bangsow C, Rubins N, Glusman G, et al. The RUNX3 gene-sequence, structure and regulated expression. Gene 2001; 279: 221-32. (Pubitemid 33132184)
5. Guo WH, Weng LQ, Ito K, et al. Inhibition of growth of mouse gastric cancer cells by Runx3, a novel tumor suppressor. Oncogene 2002; 21: 8351-5. (Pubitemid 35477876)
6. Salto-Tellez M, Peh BK, Ito K, et al. RUNX3 protein is overexpressed in human basal cell carcinomas. Oncogene 2006; 25: 7646-9. (Pubitemid 44924477)
7. Lau QC, Raja E, Salto-Tellez M, et al. RUNX3 is frequently inactivated by dual mechanisms of protein mislocalization and promoter hypermethylation in breast cancer. Cancer Res 2006; 66: 6512-20. (Pubitemid 44085605)
8. Gao F, Huang C, Lin M, et al. Frequent inactivation of RUNX3 by promoter hypermethylation and protein mislocalization in oral squamous cell carcinomas. J Cancer Res Clin Oncol 2009; 135: 739-47.
9. Kim WJ, Kim EJ, Jeong P, et al. RUNX3 inactivation by point mutations and aberrant DNA methylation in bladder tumors. Cancer Res 2005; 65: 9347-54. (Pubitemid 41508002)
10. Park WS, Cho YG, Kim CJ, et al. Hypermethylation of the RUNX3 gene in hepatocellular carcinoma. Exp Mol Med 2005; 37: 276-81. (Pubitemid 41330037)
11. Ku JL, Kang SB, Shin YK, et al. Promoter hypermethylation downregulates RUNX3 gene expression in colorectal cancer cell lines. Oncogene 2004; 23: 6736-42.
12. Li QL, Ito K, Sakakura C, et al. Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell 2002; 109: 113-24. (Pubitemid 34327521)
13. He JF, Ge MH, Zhu X, et al. Expression of RUNX3 in salivary adenoid cystic carcinoma: implication for tumor progression and prognosis. Cancer Sci 2008; 99: 1334-40. (Pubitemid 351761721)
14. Ito K, Liu Q, Salto-Tellez M, et al. RUNX3, a novel tumor suppressor, is frequently inactivated in gastric cancer by protein mislocalization. Cancer Res 2005; 65: 7743-50. (Pubitemid 41297249)
15. Wada M, Yazumi S, Takaishi S, et al. Frequent loss of RUNX3 gene expression in human bile duct and pancreatic cancer cell lines. Oncogene 2004; 23: 2401-7. (Pubitemid 38496795)
16. Bae SC, Choi JK,. Tumor suppressor activity of RUNX3. Oncogene 2004; 23: 4336-40.
17. Kleeff JL, Guweidhi A, Esposito I, et al. RUNX3 expression in primary and metastatic pancreatic cancer. J Clin Pathol 2004; 57: 294-9. (Pubitemid 38338844)
18. Nevadunsky NS, Barbieri JS, Kwong J, et al. RUNX3 protein is overexpressed in human epithelial ovarian cancer. Gynecol Oncol 2009; 112: 325-30.
19. Tsunematsu T, Kudo Y, Iizuka S, et al. RUNX3 has an oncogenic role in head and neck cancer. PLoS ONE 2009; 4: e5892.
20. Kitago M, Martinez SR, Nakamura T, et al. Regulation of RUNX3 tumor suppressor gene expression in cutaneous melanoma. Clin Cancer Res 2009; 15: 2988-94.